Expression and clinical significance of the CD47/SIRPα pathway as a candidate immunotherapy target in non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Desai, Shruti [1 ]
Villarroel-Espindola, Franz [1 ]
Gaule, Patricia [1 ]
Ducler, Adam [1 ]
Peluso, Marisa [2 ]
Lee, Benjamin [2 ]
Schalper, Kurt [1 ]
Holland, Pamela [2 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Surface Oncol, Cambridge, MA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P270
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer
    Giatromanolaki, Alexandra
    Mitrakas, Achilleas
    Anestopoulos, Ioannis
    Kontosis, Andreas
    Koukourakis, Ioannis M.
    Pappa, Aglaia
    Panayiotidis, Mihalis I.
    Koukourakis, Michael I.
    CANCERS, 2022, 14 (07)
  • [2] CD47 is a promising therapeutic target in non-small cell lung cancer
    Lau, Asa P.
    Kubli, Shawn P.
    Wakeham, Andrew
    Mak, Tak W.
    Thu, Kelsie L.
    CANCER RESEARCH, 2023, 83 (07)
  • [3] CD47/SIRPα pathway mediates cancer immune escape and immunotherapy
    Jia, Xiao
    Yan, Bingjun
    Tian, Xiaoqing
    Liu, Qian
    Jin, Jianhua
    Shi, Juanjuan
    Hou, Yongzhong
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (13): : 3281 - 3287
  • [4] Myeloid cell contexture and IL-8 expression as a candidate immunotherapy target in non-small cell lung cancer (NSCLC)
    Nagineni, Venkata Vamsi
    Schalper, Kurt
    Desai, Shruti
    Melero, Ignacio
    Sanmamed, Miguel
    Gupta, Richa
    Herbst, Roy
    Nagineni, Venkata Vamsi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [5] Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer
    Arrieta, Oscar
    Aviles-Salas, Alejandro
    Orozco-Morales, Mario
    Hernandez-Pedro, Norma
    Cardona, Andres F.
    Cabrera-Miranda, Luis
    Barrios-Bernal, Pedro
    Soca-Chafre, Giovanny
    Cruz-Rico, Graciela
    de Lourdes Pena-Torres, Maria
    Moncada-Claudio, Guadalupe
    Ramirez-Tirado, Laura-Alejandra
    CANCER MEDICINE, 2020, 9 (07): : 2390 - 2402
  • [6] Clinical significance of p-AKT pathway in non-small cell lung cancer (NSCLC)
    Yoshizawa, A.
    Fukuoka, J.
    Shilo, K.
    Franks, T. J.
    Hewitt, S. M.
    Fujii, T.
    Jen, J.
    Travis, W. D.
    Cordon-Cardo, C.
    MODERN PATHOLOGY, 2007, 20 : 335A - 335A
  • [7] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [8] Clinical significance of p-AKT pathway in non-small cell lung cancer (NSCLC)
    Yoshizawa, A.
    Fukuoka, J.
    Shilo, A.
    Franks, T. J.
    Hewitt, S. M.
    Fujii, T.
    Jen, J.
    Travis, W. D.
    Conlon-Cardo, C.
    LABORATORY INVESTIGATION, 2007, 87 : 335A - 335A
  • [9] CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer
    Hui Zhao
    Jianxin Wang
    Xiaodan Kong
    Encheng Li
    Yuanbin Liu
    Xiaohui Du
    Zhijie Kang
    Ying Tang
    Yanbin Kuang
    Zhihui Yang
    Youwen Zhou
    Qi Wang
    Scientific Reports, 6
  • [10] CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer
    Zhao, Hui
    Wang, Jianxin
    Kong, Xiaodan
    Li, Encheng
    Liu, Yuanbin
    Du, Xiaohui
    Kang, Zhijie
    Tang, Ying
    Kuang, Yanbin
    Yang, Zhihui
    Zhou, Youwen
    Wang, Qi
    SCIENTIFIC REPORTS, 2016, 6
12345